Lyra Therapeutics - 53 Year Dividend History | LYRA
Historical dividend payout and yield for Lyra Therapeutics (LYRA) since 1971. The current TTM dividend payout for Lyra Therapeutics (LYRA) as of November 20, 2024 is $0.00. The current dividend yield for Lyra Therapeutics as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.012B |
$0.002B |
|
Lyra Therapeutics Inc. is a clinical-stage therapeutics company. It is focused on the development and commercialization of novel integrated drug and delivery solutions for patients with ear, nose and throat diseases. The company's proprietary technology platform, XTreo(TM), is designed to precisely and consistently deliver medicines directly to the affected tissue. Its initial product candidates consist LYR-210 and LYR-220 which are in clinical stage. Lyra Therapeutics Inc. is based in Watertown, Mass.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
